Layoffs across health agencies have eliminated workers who handled Freedom of Information Act requests at the CDC, FDA, and ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...

In the US, the incidence of pancreatic cancer is increasing in patients of all ages, and the incidence of colorectal cancer is increasing in patients aged 15-34 years.

Adherence to ACS nutrition and activity guidelines is associated with a lower risk of death among nonsmoking survivors of obesity-related cancers, researchers found.

The most common projected cancers in adults were lung cancer, colon cancer, leukemia, bladder cancer, and stomach cancer.

(HealthDay News) — The US Food and Drug Administration (FDA) announced that it is shifting away from requiring animal testing for the development of monoclonal antibodies and other drugs and will ...

The Honoring Our Fallen Heroes Act is considered crucial by its supporters, with climate change fueling an increase in wildfire frequency and firefighting deemed carcinogenic by the World Health ...

Patients covered by Medicaid are just as likely as those with private insurance to be charged a copay for sending a message to their physician or other provider through a patient portal, a survey ...

Niraparib maintenance has a tolerable safety profile in patients with ovarian cancer, with hematologic toxicities being “the primary concern,” according to researchers. They evaluated the safety of ...

Future prospective studies and clinical trials are necessary to determine whether vitamin D supplementation can improve survival outcomes in pancreatic cancer patients,” the researchers wrote.

The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) as first-line treatment for adults with unresectable or metastatic HCC.

Due to recent layoffs, the CDC said it could not help Milwaukee deal with high levels of lead in city schools.